Literature DB >> 2217554

Photosensitized processes in vivo: proposed phototherapeutic applications.

G Jori1.   

Abstract

The use of photosensitizing dyes having intense absorption bands in the 600-900 nm spectral interval opens up new prospects in the field of photochemotherapy, because it allows the illumination of relatively large tissue volumes with no significant damage to photosensitizer-free tissues. Special interest is currently focused on the photodynamic therapy of solid tumors, because of the property of several dyes with a macrocyclic chemical structure (porphyrins, chlorins, phthalocyanines, xanthenes) to accumulate in significant amounts and be retained for prolonged periods of time by neoplastic lesions. Strategies are being developed for enhancing the selectivity of tumor targeting by photosensitizers through the exploitation of functional or biochemical differences between normal and malignant cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2217554     DOI: 10.1111/j.1751-1097.1990.tb04201.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  5 in total

Review 1.  Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.

Authors:  J C Bremner
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

Review 2.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

3.  Tumour-localising and -photosensitizing properties of liposome-delivered Ge(IV)-octabutoxy-phthalocyanine.

Authors:  V Cuomo; G Jori; B Rihter; M E Kenney; M A Rodgers
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

4.  Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine.

Authors:  C Ometto; C Fabris; C Milanesi; G Jori; M J Cook; D A Russell
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

5.  Investigation of Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) Porphyrazine for Application as Photosensitizer in Photodynamic Therapy of Cancer.

Authors:  Keiichi Sakamoto; Eiko Ohno-Okumura; Taku Kato; Masaki Watanabe; Michael J Cook
Journal:  Met Based Drugs       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.